Lung Cancer’s Hidden Layers - Summary - MDSpire
Clinical Guidelines
Feature

Lung Cancer’s Hidden Layers

Study shows that tumor complexity can limit biopsy-based diagnosis

  • April 22, 2026

  • 2 min

Share

Recent research into combined small-cell lung cancer (cSCLC) equips clinicians with new insights regarding the tumor's heterogeneity, emphasizing the challenges in accurately diagnosing this rare cancer subtype with limited biopsy samples. The study utilized advanced spatial multi-omics techniques on 19 untreated tumors, revealing a predominance of shared mutations indicating a singular clonal origin. Importantly, the findings show distinct spatial arrangements of tumor components and variations in the surrounding microenvironment, which can complicate diagnoses. A newly developed mutation-based assay aims to enhance diagnosis accuracy in challenging scenarios.

Original Source(s)

Lung Cancer’s Hidden Layers

  • April 22, 2026

Related Content

Roving Reporter Asks: What Was the Biggest Development in CGT of 2025?

IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to uncover the year’s defining breakthroughs

  • April 22, 2026

  • 1 min
High-Risk Smoldering Multiple Myeloma: BCMA-Directed CAR T-Cell Therapy Shows Activity

A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel led to a 100% measurable residual disease (MRD)-negativity rate in patients with high-risk smoldering ...

Baptist Health Heart & Vascular Care Expands Interventional Radiology Program with Nine Physicians

 Baptist Health Heart & Vascular Care announces the addition of nine highly skilled interventional radiology physicians to Baptist Health Miami Cardiac & Vascular Institute, part of Baptist Health Heart & Vascular Care, further strengthening its commitment to advanced, minimally invasive care.

  • by

  • April 21, 2026

  • 3 min